9 research outputs found

    Predictors of postal or online response mode and associations with patient experience and satisfaction in the English Cancer Patient Experience Survey

    Get PDF
    Background: Patient experience surveys are important tools for improving the quality of cancer services but the representativeness of responders is a concern. Increasingly, patient surveys which traditionally used postal questionnaires are incorporating an online response option. However, the characteristics and experience ratings of online responders are poorly understood. Objectives: To examine predictors of postal or online response mode; and associations with patient experience in the (English) Cancer Patient Experience Survey. Methods: We analysed data from 71,186 patients with cancer recently treated in National Health Service (NHS) hospitals who responded to the Cancer Patient Experience Survey 2015. Using logistic regression, we explored patient characteristics associated with greater probability of online response; and whether, after adjustment for patient characteristics, online response was associated with more or less critical evaluation of cancer care compared with postal response. Results: 4,635 (7%) of the survey participants responded online. In adjusted analyses, men (OR women vs men 0.50; 95% CI 0.46-0.54), younger (OR < 55 vs 65-74 years old 3.49; 3.21-3.80), least deprived (OR most vs least deprived quintile 0.57; 0.51-0.64), and ethnic minority (OR non-white vs white ethnicity 1.37; 1.24-1.51) patients were more likely to respond online. Compared with postal responders, after adjustment for patient characteristics, online responders had a higher likelihood of reporting an overall satisfied experience of care (OR 1.24; 1.16-1.32). For 34/49 other items, online responders more frequently reported a less than positive experience of care (8 reached statistical significance), and the associations were positive for the remaining 15/49 items (2 reached statistical significance). Conclusions: In the context of a national survey of patients living with cancer, online and postal responders tend to differ in their characteristics and rating of satisfaction; associations between online response and reported experience were generally small and mostly non-significant, but with a tendency towards less than positive ratings, though not consistently. Whether the observed associations between response mode and reported experience were causal needs to be examined using experimental survey designs.Macmillan Cancer Suppor

    Diagnostic route is associated with care satisfaction independently of tumour stage: Evidence from linked English Cancer Patient Experience Survey and cancer registration data.

    Get PDF
    BACKGROUND: Whether diagnostic route (e.g. emergency presentation) is associated with cancer care experience independently of tumour stage is unknown. METHODS: We analysed data on 18 590 patients with breast, prostate, colon, lung, and rectal cancers who responded to the 2014 English Cancer Patient Experience Survey, linked to cancer registration data on diagnostic route and tumour stage at diagnosis. We estimated odds ratios (OR) of reporting a negative experience of overall cancer care by tumour stage and diagnostic route (crude and adjusted for patient characteristic and cancer site variables) and examined their interactions with cancer site. RESULTS: After adjustment, the likelihood of reporting a negative experience was highest for emergency presenters and lowest for screening-detected patients with breast, colon, and rectal cancers (OR versus two-week-wait 1.51, 95% confidence interval [CI] 1.24-1.83; 0.88, 95% CI 0.75-1.03, respectively). Patients with the most advanced stage were more likely to report a negative experience (OR stage IV versus I 1.37, 95% CI 1.15-1.62) with little confounding between stage and route, and no evidence for cancer-stage or cancer-route interactions. CONCLUSIONS: Though the extent of disease is strongly associated with ratings of overall cancer care, diagnostic route (particularly emergency presentation or screening detection) exerts important independent effects.This work is supported by Macmillan Cancer Support grant 5995414 for which GAA and GL are joint principal investigators. GL is supported by a Cancer Research UK Advanced Clinician Scientist Fellowship Award (C18081/A18180)

    Awareness and use of online appointment booking in general practice: analysis of GP Patient Survey data

    No full text
    Background: general practices are required to provide online booking to patients in line with policy to digitise access. However, uptake of online booking by patients is currently low and there is little evidence about awareness and use by different patient groups.Aim: to examine variability in awareness and use of online appointment booking in general practice.Method: secondary analysis of two questions from the GP Practice Survey data (2018) asking about awareness and use of online booking of appointments. Multivariable logistic regression was used to examine associations with age, gender, ethnicity, deprivation, the presence of a long-term condition, long-term sickness and being deaf.Results: in total, 43.3% (277 278/647 064) of responders reported being aware of being able to book appointments online, while only 15% (93 671/641 073) reported doing so. There was evidence of variation by all factors considered, with strong deprivation gradients in both awareness and use (for example, most versus least deprived quintile OR for use: 0.63 (95% CI = 0.61 to 0.65). There was a reduction in awareness and use in patients &gt;75 years of age. Patients with long-term conditions were more aware and more likely to use online booking.Conclusion: while over 40% of patients know that they can book appointment online, the number that actually do so is far lower. With the constant push for online services within the NHS and the roll out of the NHS app, practices should be aware that not all patient groups will book appointments online and that other routes of access need to be maintained to avoid widening health inequalities.</p

    Priestley, Joseph

    Get PDF
    Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple sclerosis
    corecore